Journal of Equine Veterinary Science
Volume 27, Issue 7 , Pages 298-303 , July 2007

Intraarticular Hyaluronic Acid Supplementation in the Horse: The Role of Molecular Weight

References 

  1. Animal and Plant Health Inspection Service website. National economic cost of equine lameness, colic, and equine protozoal myeloencephalitis (EPM) in the United States, Oct 2001. Available at www.aphis.usda.gov/vs/ceah/cahm. Accessed May 18, 2006.
  2. Caron JP, Genovese RL. Principles and practices of joint disease treatment. In:  Ross MW,  Dyson SJ editor. Diagnosis and management of lameness in the horse. Philadelphia: Saunders; 2003;p. 746–763
  3. McIlwraith CW, Howard RD. Hyaluronan and its use in the treatment of equine joint disease. In:  McIlwraith CW,  Trotter GW editor. Joint disease in the horse. Philadelphia: WB Saunders Company; 1996;p. 257–269
  4. Balazs EA, Briller SO, Denlinger JL. Na-hyaluronate molecular size variations in equine and human arthritic synovial fluids and the effect on phagocytic cells. Osteoarth Symp Semin Arthritis Rheum. 1980;(Suppl 1):141–143
  5. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44:817–822
  6. McIlwraith CW. Use of sodium hyaluronate (Hyaluronan) in equine joint diseases. Equine Vet Educ. 1997;9:296–304
  7. Roneus B, Lindblad A, Lindholm A. Effects of intrarticular corticosteroid and sodium hyaluronate injections on synovial fluid production and synovial fluid content of sodium hyaluronate and proteoglycans in normal equine joints. Zentbl Vetmed A. 1993;40:10–16
  8. Tulamo RM, Heiskanen T, Salonen M. Concentration and molecular weight distribution of hyaluronate in synovial fluid from clinically normal horses and horses with diseased joints. Am J Vet Res. 1994;5:710–715
  9. Tulamo RM, Houttu J, Tupamaki A, Salonen M. Hyaluronate and large molecular weight proteoglycans in synovial fluid from horses with various arthritides. Am J Vet Res. 1996;6:932–937
  10. Nagata Y, Matsumura F, Motoyoshi H, Yamasaki H, Fukuda K, Tanaka S. Secretion of hyaluronic acid from synovial fibroblasts is enhanced by histamine: a newly observed metabolic effect of histamine. J Lab Clin Med. 1992;120:707–712
  11. Popot MA, Bonnaire Y, Guechot J, Toutain PL. Hyaluronan in horses: physiologic production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration. Equine Vet J. 2004;36:482–487
  12. Hilbert BJ, Rowley G, Antonas KN, McGill CA, Reynoldson JA, Hawkins CD. Changes in the synovia after the intra-articular injection of sodium hyaluronate into normal horse joints and after arthrotomy and experimental cartilage damage. Aust Vet J. 1985;62:182–185
  13. Lindholm A, Roneus B, Lindhlad G, Jones B. Hyaluronan turnover in the synovial fluid in metacarpophalangeal and middle carpal joints in standardbred horses. Acta Vet Scand. 1996;37:147–151
  14. Laurent UB, Fraser JR, Engstrom-Laurent A, Reed RK, Dahl LB, Laurent TC. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix. 1992;12(2):130–136
  15. Konttinen YT, Saari HT, Nordstrom D. Effect of interleukin-1 on hyaluronate synthesis by synovial fibroblast cells. Clin Rheum. 1991;10:151–154
  16. Ekman L, Nilsson G, Persson L, Lumsden J. Volume of the synovia in certain joint cavities in the horse. Acta Vet Scand. 1981;22:23–31
  17. Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res. 1997;116:3–9
  18. Gotoh S, Onaya J, Abe M. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52:817–822
  19. Balazs E. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Int. 2004;12:278–289
  20. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?. Semin Arthritis Rheum. 2002;32:10–37
  21. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheum Int. 1987;7:113–122
  22. Phillips MW. Clinical trial comparison of intra-articular sodium hyaluronate products in the horse. Equine Vet Sci. 1989;9:39–41
  23. Peloso JG, Stick JA, Caron JP, Peloso PM, Soutas-Little RW. Effects of hylan on amphotericin-induced carpal lameness in equids. Am J Vet Res. 1993;54:1527–1534
  24. Akatuska M, Yamamoto Y, Tobetto K. In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions. 1993;38:122–125
  25. Sato H, Takashi T, Ide H. Antioxidant activity of synovial fluid hyaluronic acid. Arthritis Rheum. 1988;31:63–71
  26. Punzi L, Schiavon F, Cavasin F. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheum. 1989;7:247–250
  27. Wobig M, Bach G, Beks P, Dickut A, Runzheiner J, Schwieger G, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of Hylan G-F 20 and a lower molecular weight hyaluronan. Clin Ther. 1999;21:1549–1562
  28. Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomized controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheum Int. 2006;26:325–330
  29. Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiyama Y. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol. 1998;61:125–135
  30. Kawcak CE, Frisbie DD, Trotter GW, McIlwraith CW, Gillette SM, Powers BE, et al. Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res. 1997;58:1132–1140
  31. Asheim A, Lindblad G. Intra-articular treatment of arthritis in race-horses with sodium hyaluronate. Acta Vet Scand. 1976;17:379–394
  32. Rose RJ. The intra-articular use of sodium hyaluronate for the treatment of osteo-arthrosis in the horse. N Z Vet J. 1979;27:5–8
  33. Rydell N, Balazs A. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop Rel Res. 1971;80:25–32
  34. Auer JA, Fackelman GE, Gingerich DA, Fetter AW. Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis. Am J Vet Res. 1979;41:568–575
  35. Gingerich DA, Auer JA, Fackelman GE. Effect of exogenous hyaluronic acid on joint function in experimentally induced equine osteoarthritis: dosage titration studies. Res Vet Sci. 1981;30:192–197
  36. White GW, Sittes T, Hamm J, Pool R. Evaluation of the efficacy of various sodium hyaluronate preparations in an induced equine carpitis model. J Equine Vet Sci. 1999;19:331–337
  37. Brusie RW, Sullins KE, White NA, Coffin PC, Parker GA, Anver MR, et al. Evaluation of sodium hyaluronate therapy in induced septic arthritis in the horse. Equine Vet J. 1992;11(Suppl):18–23
  38. Gaustad G, Larsen S. Comparison of polysulfated glycosaminoglycan and sodium hyaluronate with placebo in treatment of traumatic arthritis in horses. Equine Vet J. 1995;27:356–362
  39. Carter BG, Bertone AL, Weisbrode SE, Bailey MQ, Andrews JM, Palmer JL. Influence of methylprednisolone acetate on osteochondral healing in exercised tarsocrural joints of horses. Am J Vet Res. 1996;6:914–922
  40. Shoemaker RS, Bertone AL, Martin GS, McIlwraith CW, Roberts ED, Pechman R, et al. Effects of intra-articular administration of methylprednisolone acetate on normal articular cartilage and on healing of experimentally induced osteochondral defects in horses. Am J Vet Res. 1992;53:1446–1453
  41. Frisbie DD, Kawcak CE, Baxter GM, Trotter GW, Powers BE, Lassen ED, et al. Effects of 6 alpha-methylprednisolone acetate on an equine osteochondral fragment exercise model. Am J Vet Res. 1998;59:1619–1628
  42. Murphy DJ, Todhunter RJ, Fubini SL, Vernier-Singer M, Straubinger RK, Lust G. The effects of methylprednisolone on normal and monocyte-conditioned medium-treated articular cartilage from dogs and horses. Vet Surg. 2000;29:546–557
  43. Dechant JE, Baxter GM, Frisbie DD, Trotter GW, McIlwraith CW. Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro. Equine Vet J. 2003;35:444–450
  44. Rydell NW, Butler J, Balazs EA. Hyaluronic acid in synovial fluid. Acta Vet Scand. 1970;11:139–155
  45. Doyle AJ, Stewart AA, Constable PD, Eurell JC, Freeman DE, Griffon DJ. Effects of sodium hyaluronate and methylprednisolone acetate on proteoglycan synthesis in equine articular cartilage explants. Am J Vet Res. 2005;66:48–53
  46. Aviad AD, Houpt JB. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): How significant is it?. J Rheum. 1994;21:297–301

PII: S0737-0806(07)00196-7

doi: 10.1016/j.jevs.2007.05.006

Journal of Equine Veterinary Science
Volume 27, Issue 7 , Pages 298-303 , July 2007

Article Tools